HOME HELP FEEDBACK E-MAIL ALERTS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Similar articles in this journal Alert me to new issues of the journal Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Somjetlerdcharoen, A. Search for Related Content PubMed Articles by Somjetlerdcharoen, A. Related Collections Food and Agriculture Organization Shrimp Network of Aquaculture Centres in Asia-Pacific Thailand Shellfish diseases Treatments

Chloramphenicol Concerns in Shrimp Culture

Document format: pdf

Publisher: Network of Aquaculture Centres in Asia-Pacific

Creation date: March 2002

Due to the detection of chloramphenicol residue in black tiger shrimp (P. monodon) exports to European Union (EU) in September 2001, an ad hoc committee was established by the Department of Fisheries (DOF) for the investigation and monitoring of the use of chloramphenicol and to find solutions to any problems. In EU and the USA, the use of chloramphenicol is banned in aquatic animals cultured for human food. Similarly, DOF has had a strict policy to prohibit this drug in all aquaculture, particularly in treatment of P. monodon disease. However, in some cases, farmers may not be aware that chloramphenicol is present as a component in treatments for shrimp disease that are commonly sold under other names. Following a strong recommendation of the Food and Drug Committee, the Ministry of Public Health issued an order banning the use of chloramphenicol and its derivatives in all animals for human consumption, effective since 1 September 1988. Therefore, the author would like to provide a general background of this drug.

Key Words: NACA • Chloramphenicol • Aquatic Animal Health • Shrimp Disease • Thailand • Black Tiger Shrimp • FAO